Iohexol and iopamidol: second-generation nonionic radiographic contrast media

Area of Science:

• Radiology
• Medical Imaging
• Pharmacology

Background:

• First-generation nonionic contrast media like metrizamide had limitations.
• Conventional ionic contrast media often exhibit high osmolality.
• Advancements in contrast media aim to improve patient safety and usability.

Purpose of the Study:

• To review the properties of iohexol and iopamidol.
• To compare these agents with metrizamide and ionic contrast media.
• To discuss the clinical significance of low osmolality contrast media.

Main Methods:

• Review of physical and chemical properties.
• Analysis of clinical studies using randomized, double-blind comparisons.
• Discussion of osmolality and adverse reaction data.

Main Results:

• Iohexol and iopamidol represent second-generation nonionic contrast media.
• Low osmolality solutions are associated with reduced adverse reactions.
• Ready-to-use solutions offer practical advantages over lyophilized forms.

Conclusions:

• Iohexol and iopamidol demonstrate significant improvements in nonionic contrast media.
• Low osmolality is a key factor in minimizing adverse events.
• Further definition of the clinical roles for iohexol and iopamidol is warranted.